Viking Therapeutics, Inc.

Q1 2019 13F Holders

Symbol: VKTX
CUSIP: 92686J106
Type: Equity
Class: COM
Num filers: 169
Total reported value, excl. options: $455M

Compare 2019 Q1 to

Manager	Report Date	Value ($000)	Shares	Option Type